Biomarkers for sensitivity to anti-igf1r therapy

Details Biomarkers for sensitivity to anti-igf1r therapy Biomarkers for sensitivity to anti-igf1r therapy

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01)

Patent

CA 2709827

The present invention provides, for example, methods for conveniently determining if a cancerous condition in a subject will be responsive to an IGF1R inhibitor. The invention includes patient selection methods and methods of treatment.

L'invention concerne, par exemple, des procédés pour déterminer de façon commode si une affection cancéreuse chez un sujet sera réactive à un inhibiteur d'IGF1R. L'invention comprend des procédés de sélection de patients et des procédés de traitement.

Affiliated with

Also associated with

Rating

Biomarkers for sensitivity to anti-igf1r therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers for sensitivity to anti-igf1r therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for sensitivity to anti-igf1r therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1723571